Last $5.00 USD
Change Today -0.14 / -2.72%
Volume 13.5K
CPIX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/15/14 All times are local (Market data is delayed by at least 15 minutes).

cumberland pharmaceuticals (CPIX) Key Developments

Cumberland Pharmaceuticals, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Cumberland Pharmaceuticals, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported Revenue was $9.75 million against $7.081 million a year ago. Operating income was $1.22 million against loss of $1.14 million a year ago. Income before income taxes was $1.23 million against loss of $1.112 million a year ago. Net income attributable to common shareholders was $722.57 million against loss of $639.02 million a year ago. Diluted earnings per share were $0.04 against loss of $0.03 a year ago. For the six months, the company reported Revenue was $17.84 million against $17.339 million a year ago. Operating income was $1.62 million against $0.185 million a year ago. Income before income taxes was $1.696 million against $0.288 million a year ago. Net income attributable to common shareholders was $1.009 million against $0.216 million a year ago. Diluted earnings per share were $0.06 against $0.01 a year ago. Net cash provided by operating activities was $1.82 million against $1.79 million a year ago. Additions to property and equipment were $0.048 million against $0.069 million a year ago. Additions to intangible assets were $0.732 million against $1.83 million a year ago.

Cumberland Pharmaceuticals Seeks Acquisitions

Cumberland Pharmaceuticals, Inc. (NasdaqGS:CPIX) will consider acquisitions. Cumberland has entered into a new three year line of credit with SunTrust Bank providing up to $20 million in debt financing availability to support Cumberland's growth and acquisition initiative.

Cumberland Pharmaceuticals, Inc. to Report Q2, 2014 Results on Aug 05, 2014

Cumberland Pharmaceuticals, Inc. announced that they will report Q2, 2014 results at 5:00 PM, Eastern Standard Time on Aug 05, 2014

Cumberland Pharmaceuticals, Inc., Q2 2014 Earnings Call, Aug 05, 2014

Cumberland Pharmaceuticals, Inc., Q2 2014 Earnings Call, Aug 05, 2014

Cumberland Pharmaceuticals Inc. Enters into a Revolving Credit Loan Agreement with Sun Trust Bank

On June 26, 2014, Cumberland Pharmaceuticals Inc. entered into a revolving credit loan agreement with SunTrust Bank. The loan agreement provides for an aggregate principal amount up to $20 million. It provides an initial revolving line of credit of up to $12 million with the ability for Cumberland to increase the amount to $20 million, under certain conditions. There are no borrowings under the loan agreement and it expires on June 26, 2017. The interest rate is based on a LIBOR pricing grid as referenced in the agreement.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CPIX:US $5.00 USD -0.14

CPIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cubist Pharmaceuticals Inc $66.16 USD -0.98
Durect Corp $1.60 USD -0.01
Ironwood Pharmaceuticals Inc $12.59 USD -0.68
Pacira Pharmaceuticals Inc/DE $99.61 USD -4.61
Sucampo Pharmaceuticals Inc $6.55 USD -0.06
View Industry Companies
 

Industry Analysis

CPIX

Industry Average

Valuation CPIX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.8x
Price/Book 1.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CUMBERLAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.